A Phase I Study of SIM0532 in Adult Participants With Advanced Solid Tumors

NCT07749703 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

346

Enrollment

INDUSTRY

Sponsor class

Conditions

Histologically or Cytologically Confirmed Advanced Solid Tumors

Interventions

DRUG: SIM0532 Tablets

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.

Collaborators

[object Object]